[{"NetIncomeLoss_3_FY_USD":-311513.0,"DeferredTaxAssetsOperatingLossCarryforwards_0_FY_USD":22000.0,"RepaymentsOfRelatedPartyDebt_3_FY_USD":277687.0,"TemporaryEquityCarryingAmountAttributableToParent_0_FY_USD":127040070.0,"TemporaryEquitySharesOutstanding_0_FY_shares":12704007.0,"AssetsCurrent_0_FY_USD":1200872.0,"IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_3_FY_USD":-65000.0,"StockIssuedDuringPeriodValueNewIssues_3_FY_USD":25000.0,"NetCashProvidedByUsedInInvestingActivities_3_FY_USD":-135700000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_3_FY_USD":0.0,"AccruedLiabilitiesCurrent_0_FY_USD":112579.0,"CommitmentsAndContingencies_0_FY_USD":null,"StockholdersEquityNoteStockSplitConversionRatio1_3_FY_pure":1.0,"PreferredStockSharesOutstanding_0_FY_shares":0.0,"ProceedsFromRelatedPartyDebt_3_FY_USD":277687.0,"Liabilities_0_FY_USD":4867188.0,"Cash_0_FY_USD":1094556.0,"IncreaseDecreaseInAccountsPayable_3_FY_USD":5109.0,"PaymentsOfStockIssuanceCosts_3_FY_USD":8100000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_FY_USD":0.0,"NetCashProvidedByUsedInFinancingActivities_3_FY_USD":137101092.0,"ProceedsFromIssuanceOfPrivatePlacement_3_FY_USD":4714000.0,"AssetsHeldInTrustNoncurrent_0_FY_USD":135706395.0,"PaymentOfFinancingAndStockIssuanceCosts_3_FY_USD":3337908.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_0_FY_USD":0.0,"IncreaseDecreaseInAccruedLiabilities_3_FY_USD":112579.0,"SaleOfStockPricePerShare_0_FY_USD":10.0,"PrepaidExpenseCurrent_0_FY_USD":106316.0,"UnrecognizedTaxBenefits_0_FY_USD":0.0,"ProceedsFromIssuanceOfCommonStock_3_FY_USD":135700000.0,"OtherUnderwritingExpense_3_FY_USD":4800000.0,"CashEquivalentsAtCarryingValue_0_FY_USD":1100000.0,"AdditionalPaidInCapital_0_FY_USD":5311049.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_3_FY_pure":0.21,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_FY_USD":1094556.0,"SaleOfStockNumberOfSharesIssuedInTransaction_3_FY_shares":1770000.0,"AccountsPayableCurrent_0_FY_USD":5109.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3_FY_USD":1094556.0,"LiabilitiesCurrent_0_FY_USD":117688.0,"NetCashProvidedByUsedInOperatingActivities_3_FY_USD":-306536.0,"EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_3_FY_pure":-0.21,"OperatingLossCarryforwards_0_FY_USD":100000.0,"DeferredTaxAssetsGross_0_FY_USD":65000.0,"IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_3_FY_USD":65000.0,"RetainedEarningsAccumulatedDeficit_0_FY_USD":-311513.0,"TemporaryEquityRedemptionPricePerShare_0_FY_USD":10.0,"StockholdersEquity_0_FY_USD":5000009.0,"ProfitLoss_3_FY_USD":-311513.0,"SharePrice_0_FY_USD":10.0,"DeferredTaxAssetsValuationAllowance_0_FY_USD":65000.0,"PreferredStockSharesAuthorized_0_FY_shares":1000000.0,"LiabilitiesAndStockholdersEquity_0_FY_USD":136907267.0,"InvestmentIncomeInterest_3_FY_USD":6395.0,"OperatingIncomeLoss_3_FY_USD":-317908.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_FY_USD":0.0,"Assets_0_FY_USD":136907267.0,"IncreaseDecreaseInPrepaidExpense_3_FY_USD":106316.0,"Ticker":"PNT","CIK":"1811764","name":"THERAPEUTICS ACQUISITION CORP.","OfficialName":"POINT Biopharma Global Inc. Common Stock","form":"10-K","period":"20201231","fy":"2020.0","fp":"FY","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"812904697.0","Country":"United States","Sector":"Consumer Durables","Industry":"Specialty Chemicals","Market":"NASDAQ","SP500":"nan","filed":"20210304"}]